Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03396835 · ClinicalTrials.gov registry record · NA
Desaturation Validation of INVSENSOR00009
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03396835 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 16 participants.
The verdict
NCT03396835, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study is designed to measure the trending accuracy of a noninvasive measurement of cerebral oxygen saturation. One Large sensor (adult sensor) and one INVSENSOR00009 will be placed on the subject's forehead. The values obtained by the INVSENSOR00009 will be compared to the values collected with the adult sensor.Data will be collected from healthy adult subjects while undergoing a desaturation procedure wherein the concentration of oxygen inhaled is slowly reduced until the subject's arterial oxygen saturation is approximately 70%. The subject will then be returned to inhaling room air.
Interventions
- DEVICE INVSENSOR00009
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-12-18 |
| Est. Completion | 2018-01-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03396835
The ClinicalTrials.gov registry entry for NCT03396835 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INVSENSOR00009 is the first listed.
NCT03396835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03396835 about?
NCT03396835 is a clinical study titled "Desaturation Validation of INVSENSOR00009". This study is designed to measure the trending accuracy of a noninvasive measurement of cerebral oxygen saturation. One Large sensor (adult sensor) and one INVSENSOR00009 will be placed on the subject's forehead. The values obtained by the INVSENSOR00009 will be compared to the values collected with...
What is the current status of trial NCT03396835?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-12-18. Estimated completion is 2018-01-16.
What interventions are being tested in trial NCT03396835?
The interventions under investigation include: INVSENSOR00009 (DEVICE).
Who is sponsoring clinical trial NCT03396835?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.